TUBERCULOSE EXTRAPULMONAR: UMA REVISÃO DE LITERATURA

Tuberculosis (TB) is an infectious disease with very ancient records in the history of civilization and has a natural course that is well described in medicine. It is an infection that mainly affects the respiratory tract, but can affect other organs of the body, even simultaneously. When TB occurs in organ systems other than the lungs, it is called extrapulmonary TB (EPTB). Various forms of EBTB are described in the literature, all with a higher incidence in individuals with a compromised immune system. The diagnosis of forms of EPTB depends on the identification of the etiological agent in infected tissue samples and has become simpler with the advent of nucleic acid amplification tests (NAATs). Drugs for treating TB include bactericidal and bacteriostatic drugs in a directly offered and regular treatment regimen for a prolonged period. It is necessary to strengthen PHC in all areas for adequate control of TB - greater access to technologies that facilitate and make diagnosis faster and greater empowerment in the population's health regarding prevention and greater adherence to treatment.